On April 2, 2026, FOXO Technologies Inc. filed an 8-K report detailing the approval of an amendment to its Certificate of Incorporation. The amendment, approved by the Majority Stockholder, Rennova Health, Inc., will increase the authorized shares of Class A Common Stock from 10 billion to 25 billion shares. This decision was made to provide the company with greater flexibility in managing its capital structure and to support future growth initiatives. The record date for this approval was set for March 20, 2026, with the Majority Stockholder holding approximately 97.59% of the voting rights. The company has filed a preliminary Information Statement on Schedule 14C with the SEC regarding this matter and plans to mail the definitive Information Statement to stockholders shortly. The increase in authorized shares is expected to enhance the company's ability to raise capital and pursue strategic opportunities, although it may also lead to dilution of existing shares. The effective date of the increase will be determined by the Board of Directors without further stockholder approval.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.